In Re Quigley Co., Inc.

383 B.R. 19, 2008 Bankr. LEXIS 408, 49 Bankr. Ct. Dec. (CRR) 158, 2008 WL 495646
CourtUnited States Bankruptcy Court, S.D. New York
DecidedFebruary 26, 2008
Docket17-10355
StatusPublished
Cited by14 cases

This text of 383 B.R. 19 (In Re Quigley Co., Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Quigley Co., Inc., 383 B.R. 19, 2008 Bankr. LEXIS 408, 49 Bankr. Ct. Dec. (CRR) 158, 2008 WL 495646 (N.Y. 2008).

Opinion

MEMORANDUM DECISION AND ORDER CONCERNING VOTING RIGHTS AND BALLOTING AND SOLICITATION MATERIALS

STUART M. BERNSTEIN, Chief Judge.

The debtor, Quigley Company, Inc. (“Quigley”), submitted a proposed order approving its current disclosure statement and the proposed ballot that it plans to use to solicit votes from the individuals that hold asbestos personal injury claims (the “Asbestos PI Claims”). The Ad Hoc Committee of Tort Victims (the “Ad Hoc Committee”) objected to the proposed ballot, and requested certain modifications. The modifications are intended to identify Asbestos PI Claimants who live in so-called tort reform states, described below, and allege causes of action that are currently unenforceable under the laws of their home states. In substance, the Ad Hoc Committee contends that such creditors do not hold “claims,” and are not entitled to vote. For the reasons that follow, the objection is overruled.

BACKGROUND

A. Introduction

The underlying facts, which are not disputed, are detailed in the Court’s prior opinions, In re Quigley Co., Inc., 346 B.R. 647 (Bankr.S.D.N.Y.2006)(“Quigley I”) and In re Quigley Co., Inc., 377 B.R. 110 (Bankr.S.D.N.Y.2007)(“Quigley II”). I assume familiarity with those opinions, and highlight the facts necessary to understand the disposition of the current dispute. Quigley had been engaged in the business of developing, producing and marketing a broad range of refractories and related products. Some of these products contained asbestos. (Fifth Amended And Restated Disclosure Statement With Respect To Quigley Company, Inc. Fourth Amended And Restated Plan Of Reorganization Under Chapter 11 Of The Bankruptcy Code, dated November 5, 2007 (“DS”), at 20-21 (see ECF Doc. # 1257).) In 1968, Pfizer & Co., Inc., Pfizer Inc.’s predecessor (collectively “Pfizer”), acquired Quigley, and in 1992, Pfizer sold substantially all of Quigley’s assets to Minteq International, Inc. Under the sale terms, Quigley and Pfizer retained all liability stemming from Quigley’s distribution and use of asbestos-containing products. (Id.) Since the sale, Quigley’s only function has been to manage the hundreds of thousands of asbestos personal injury claims (the “Asbestos PI Claims”) asserted against it. (DS, at 21-22.) Quigley estimates that as of the petition date, 212,000 Asbestos PI Claims were pending or would be asserted against it. (DS, at 9.)

B. Quigley’s Bankruptcy

Quigley filed its chapter 11 petition on September 3, 2004. On May 18, 2007, it filed its Fifth Amended Disclosure Statement With Respect to Quigley Company, Inc., Fourth Amended Plan Of Reorganization Under Chapter 11 Of the Bankrupt *22 cy Code (ECF Doc. # 1097) and the Quig-ley Company, Inc., Fourth Amended Plan Of Reorganization Under Chapter 11 of the Bankruptcy Code (ECF Doc. # 1098). Quigley simultaneously moved for an order approving, among other things, the adequacy of its disclosure statement and the proposed solicitation procedures. 1

The current Plan, like its predecessors, places all of the Asbestos PI Claims into Class 4. Class 4 claims will be channeled into a Trust, and paid pursuant to the Trust Distribution Procedures (“TDP”) established under the Plan. The Plan divides the Asbestos PI Claims into the following seven categories of impairment, and ascribes values, for distribution purposes, to each category:

Disease Type 2 Scheduled Value
Mesothelioma (Level VII) 200,000
Lung Cancer 1 (Level VI) _ 35,000
Lung Cancer 2 (Level V) None 3
Other Cancer (Level IV) 15,000
Severe Asbestosis (Level III) 35,000
Asbestosis/Pleural Disease (Level II) 5,000
Asbestosis/Pleural Disease (Level I) 2,000
(DS, at 89-91.)

C. The Current Dispute

The Ad Hoc Committee and the United States Trustee objected to the Disclosure Statement. The majority of the objections challenged the adequacy of the disclosure, and were either resolved or overruled at the disclosure statement hearing. The Ad Hoc Committee also argued that the Plan was unconfirmable as a matter of law. The legal objections were overruled by the Court in Quigley II.

Quigley thereafter presented a proposed order approving the Disclosure Statement and proposed individual and master ballots (collectively, the “Ballot”). 4 A lawyer that *23 represents more than one Asbestos PI Claimant can use the master ballot, rather than file an individual ballot for each client. The individual ballot is designed for use by a single Asbestos PI Claimant. The Ballot requires the Class 4 Asbestos PI Claimants or their counsel to provide each Asbestos PI Claimant’s (1) name; (2) social security number; (3) date of birth; (4) date of death, if applicable; (5) disease type, as defined in the TDP; (6) whether or not the claimant is a party to the Pfizer Settlement Agreement; 5 (7) the claimant’s law firm (master ballot only); and (8) whether the claimant votes to accept or reject the Plan.

The Ad Hoc Committee objected to the proposed Ballot, 6 and the Continental Casualty Company and the Continental Insurance Company also objected. 7 The Ad Hoc Committee argued that the laws of four states—Texas, Florida, Georgia and Ohio (collectively, the “Tort Reform States”)—preclude Asbestos PI Claimants who suffer from non-malignant impairments and cannot produce certain medical evidence from prosecuting their causes of action in state court. As a result, the holders of those “claims” should not be allowed to vote on the Plan.

The proposed Ballot did not elicit the information that the Ad Hoc Committee said it needed to identify the allegedly ineligible claims. As a result, the Ad Hoc Committee proposed modifications to the Ballot that called for six additional pieces of information: (a) the claimant’s state of residence; (b) the date of the claimant’s original medical diagnosis; (c) the state(s) in which the claimant alleges exposure; (d) the state in which the claimant’s lawsuit was filed; (e) the date on which the lawsuit was filed; and (f) if the claimant lives in a Tort Reform State, whether the claimant possesses the type of medical report that would allow the claimant to proceed with its state court action.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
383 B.R. 19, 2008 Bankr. LEXIS 408, 49 Bankr. Ct. Dec. (CRR) 158, 2008 WL 495646, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-quigley-co-inc-nysb-2008.